A GLP-1(Glucagon Like Peptide) agonist that helps to suppress your appetite and delays gastric emptying, which regulates caloric intake and help you to lose weight
Cagrilintide is a long-acting analog of amylin, a peptide hormone co-secreted with insulin with broad effects on satiety, gastrointestinal motility, glucagon secretion, bone, muscle, fat, and the cardiovascular system
People with certain medical conditions or a history of specific thyroid tumors, pancreatitis, or gallbladder disease may not qualify
A comparable pattern emerged for depressive symptoms with chronic disease (DCD), where excluding one article (Yaikwawong et al., 2024) reduced heterogeneity from 93% to 78%
Market Share Projections Novo Nordisk itself forecasts that oral weight-loss drugs will capture more than one-third of the total GLP-1 market by 2030
How to properly inspect tirzepatide before each injection Visual inspection should become automatic